Internal Medicine · Elizabethtown, KY
NPI
1679564439
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
914 N Dixie Ave, Ste 304
Elizabethtown, KY, 42701
Phone (270) 769-1049
Groups this clinician bills Medicare through
Medicare paid, 2024
$339K
5,226 services
Medicare patients, 2024
973
Average age 78
Drug cost, 2024
$2.7M
34,709 prescriptions
Company payments, 2025
$714
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Godfrey was code 99214 (office e&m - established), 1,509 times for 628 patients. In total Christopher J Godfrey billed 5,226 services in 45 codes, and Medicare paid $339K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,509 | 628 | $81.77 | $123K |
| 99309 SNF E&M | Facility | 690 | 189 | $78.42 | $54K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 630 | 434 | $10.91 | $6,874 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 460 | 460 | $125.75 | $58K |
| 36415 Venipuncture Blood Collection | Office | 356 | 207 | $8.63 | $3,072 |
| 99213 Office E&M - Established | Office | 314 | 245 | $55.11 | $17K |
| 99306 SNF E&M | Facility | 212 | 195 | $137.55 | $29K |
| G0008 Administration of influenza virus vaccine | Office | 124 | 122 | $29.21 | $3,622 |
| 90662 Vaccine Product | Office | 120 | 118 | $80.48 | $9,657 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 77 | 59 | $39.63 | $3,052 |
| 99308 SNF E&M | Facility | 75 | 45 | $50.35 | $3,776 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 55 | 13 | $47.03 | $2,587 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 50 | 44 | $155.52 | $7,776 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 47 | 44 | $62.92 | $2,957 |
| 99204 Office E&M - New | Office | 29 | 29 | $79.45 | $2,304 |
By year: 2022 $220K for 3,142 services; 2023 $282K for 3,848 services; 2024 $339K for 5,226 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 356 | 207 | $8.63 | $3,072 |
| 87428 Infectious Agent Detection by DNA/RNA | 47 | 44 | $62.92 | $2,957 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Godfrey prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,526 prescriptions and refills. In total Christopher J Godfrey wrote 34,709 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,526 | 3,033 | 318 | $17K |
| Eliquis Apixaban | 1,076 | 1,291 | 138 | $562K |
| Atorvastatin Calcium Generic | 1,038 | 2,213 | 259 | $11K |
| Metoprolol Succinate Generic | 992 | 1,935 | 230 | $15K |
| Rosuvastatin Calcium Generic | 932 | 2,333 | 256 | $11K |
| Pantoprazole Sodium Generic | 870 | 1,714 | 223 | $13K |
| Furosemide Generic | 870 | 1,350 | 181 | $3,991 |
| Amlodipine Besylate Generic | 860 | 1,926 | 224 | $5,146 |
| Potassium Chloride Generic | 785 | 1,324 | 176 | $18K |
| Gabapentin Generic | 689 | 903 | 138 | $6,267 |
| Lisinopril Generic | 560 | 1,238 | 139 | $3,603 |
| Lorazepam Generic | 531 | 542 | 94 | $2,315 |
| Duloxetine Hcl Generic | 527 | 902 | 99 | $12K |
| Losartan Potassium Generic | 521 | 1,164 | 130 | $4,670 |
| Carvedilol Generic | 503 | 935 | 110 | $4,156 |
Brand drugs: 5,587 claims; generic drugs: 28,892 claims; opioid claims: 467.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher J Godfrey $714 ($714 in general payments such as food, travel and fees) from 20 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $190.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $190 |
| Abbvie Inc. ABBV | 10 | $137 |
| Novo Nordisk Inc NVO | 2 | $34.53 |
| Averitas Pharma Inc. | 1 | $34.43 |
| Exact Sciences Corporation EXAS | 2 | $29.94 |
| GlaxoSmithKline, LLC. GSK | 2 | $29.8 |
| Antares Pharma, Inc. | 1 | $26.43 |
| Axsome Therapeutics, Inc. AXSM | 1 | $22.64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $22.28 |
| Daiichi Sankyo Inc. 4568.T | 1 | $21.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.